Октреотид
RxNorm 7617· ATC H01CB02· octreotide
KR · 한국Препарати в Кореї (8)
- 옥트스타틴주(옥트레오티드아세트산염)(주)한국비엠아이
- 옥트스타틴주(옥트레오티드아세트산염)(주)한국비엠아이
- 옥트스타틴주(옥트레오티드아세트산염)(주)한국비엠아이
- 산도스타틴라르주사10밀리그램(옥트레오티드아세트산염)한국노바티스(주)
- 산도스타틴라르주사20밀리그램(옥트레오티드아세트산염)한국노바티스(주)
- 산도스타틴라르주사30밀리그램(옥트레오티드아세트산염)한국노바티스(주)
- 산도스타틴주사0.1밀리그램/밀리리터(옥트레오티드아세트산염)한국노바티스(주)
- 산도스타틴주사0.1밀리그램/밀리리터(옥트레오티드아세트산염)한국노바티스(주)
U.S. drug label (openFDA)
Mycapssa — indications, dosage, warnings, adverse events →Хімія (PubChem)
- Молекулярна формула
- C49H66N10O10S2
- Молекулярна маса
- 1019.2 g/mol
- Назва IUPAC
- (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
- InChIKey
- DEQANNDTNATYII-OULOTJBUSA-N